课题基金 / 基金详情

COMPUTER PROGRAMS FOR ANALYSIS OF LABORATORY AND CLINICAL DATA

COMPUTER PROGRAMS FOR ANALYSIS OF LABORATORY AND CLINICAL DATA
用于分析实验室和临床数据的计算机程序
批准号:
3878049
负责人:
D RODBARD
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

D RODBARD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have developed an improved method for analysis of the calibration curves which arise in agarose and polyacrylamide gel electrophoresis of linear duplex DNA fragments using continuous or pulsed-field conditions. We employ a "four parameter logistic" model, which introduces one more parameter than was used previously in a rectangular hyperbola model. This method provides better goodness of fit, better precision, and reduced bias. The method is widely applicable, especially in studies of physical mapping of the human genome and genetic linkage analysis. A new program, DNAFIT, has been developed to implement this method for routine analysis with semi-automated methods involving digitizing tablets. The method provides improved quality control for routine laboratory analyses and also facilitate choice of optimal gel concentration for a desired molecular weight range. We have developed improved methods for detection and characterization of episodic hormone secretion, and to estimate the instantaneous rate of hormone secretion using deconvolution analysis. These methods have been applied to several clinical investigations of the dynamics of LH, FSH, prolactin, ACTH, cortisol, and beta-endorphin. New methods have been developed to evaluate coincidence of pulses in two hormonal time series. These include the concept of "specific concordance" as a function of threshold levels and adjustable lag times, and also uses the Kappa statistic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF OPIOID RECEPTORS IN BRAIN AND PERIPHERAL TISSUES
CHARACTERIZATION OF OPIOID AND PEPTIDE RECEPTORS IN BRAIN AND PERIPHERAL TISSUES
CHARACTERIZATION OF OPIOID AND PEPTIDE RECEPTORS IN BRAIN AND PERIPHERAL TISSUES
COMPUTER PROGRAMS TO AID INTENSIVE INSULIN THERAPY FOR TYPE-1 DIABETES MELLITUS
海外基金